Hypocalcemia following pamidronate administration for bone metastases of solid tumor: Three clinical case reports

Journal of Pain and Symptom Management

Volumn 25, Issue 2, 2003, Pages 185-190

  Champallou, Christophe ^a   Basuyau, Jean Pierre ^a   Veyret, Corine ^a   Chinet, Paule ^a   Debled, Marc ^a   Chevrier, Annie ^a   Grongnet, Marie Hélène ^a   Brunelle, Philippe ^a  

^a CENTRE HENRI BECQUEREL   (France)

Author keywords

Bisphosphonates; Bone metastases; Hypocalcemia; Pamidronate

Indexed keywords

ANTIANDROGEN; CALCIFEDIOL; CLODRONIC ACID; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GONADORELIN; METHOTREXATE; MILTEFOSINE; MITOMYCIN; MITOXANTRONE; NAVELBINE; PACLITAXEL; PAMIDRONIC ACID; PARATHYROID HORMONE; TRASTUZUMAB;

ADULT; ARTICLE; BONE DEVELOPMENT; BONE METASTASIS; BREAST TUMOR; CALCIUM BLOOD LEVEL; CANCER SURGERY; CASE REPORT; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; LABORATORY TEST; MALE; ONSET AGE; OSTEOLYSIS; PARATHYROID GLAND; PROSTATE CANCER; RADIOTHERAPY; RISK FACTOR; SKIN METASTASIS; SOLID TUMOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; HYPOCALCEMIA; MALE; MIDDLE AGED;

EID: 0037317210     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(02)00644-9     Document Type: Article

References (18)

1. Lhortholary A., Jadaud E., Berthaud P. Bisphosphonates et métastases osseuses. Bull Cancer. 86:1999;732-738.
2. Rodan G.A., Fleisch H.A. Bisphosphonates. mechanisms of action J Clin Invest. 97:1996;2692-2696.
3. Hermus A., Beex L., van Liessum P.et al. Hypocalcemia due to osteoblastic metastases and diminished parathyroid reserve in a patient with advanced breast cancer. Klin Wochenschr. 15:1988;643-646.
4. Wiegand M.C., Burshell A., Jaspan J., Odugbesan A.O. Case report. clinical hypocalcemia: the endocrine conference of the Alton Ochsner Medical Institutions and Tulane University Medical Center Am J Med Sci. 308:1994;255-258.
5. Riancho J.A., Arjona R., Echevarria S.et al. Tumoral hypocalcemia. Rev Clin Esp. 184:1989;187-189.
6. Grieve R.J., Dixon P.F., Roberts H., Hunter R.D. Hypocalcemia. an anusual complication of successful chemotherapy for metastatic breast cancer Clin Oncol. 9:1983;337-342.
7. ASCO Guideline on the role of bisphosphonates in breast cancer. J Clin Oncol. 18:2000;1378-1391.
8. Conte P.F., Latreille J., Mauriac L.et al. Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate. results of a multinational randomized controlled trial J Clin Oncol. 14:1996;2552-2559.
9. Johnson M.J., Falcon M.T. Symptomatic hypocalcemia with oral clodronate. J Pain Symptom Manage. 15(2):1998;140-142.
10. Schussheim D.H., Jacobs T.P., Silverberg S.J. Hypocalcemia associated with alendronate. Ann Intern Med. 130:1999;329.
11. Stuckey B.G., Lim E.M., Kent G.N.et al. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism. profound hypocalcemia, rapid response, and prolonged remission J Bone Miner Res. 16(9):2001;1719-1723.
12. Kashyap A.S., Kashyap S. Hypoparathyroidism unmasked by alendronate. Postgrad Med J. 76(897):2000;417-418.
13. Mishra A., Wong L., Jonklaas J. Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism. Endocrine. 14(2):2001;159-164.
14. Comlekci A., Biberoglu S., Hekimsoy Z.et al. Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastases following administration of pamidronate. Int Med. 37:1998;396-397.
15. Chong G., Hoang T., Davis I.D. Symptomatic hypocalcemia following intravenous pamidronate in cancer patients. Aust NZ Med. 29:1999;96-97.
16. Sims E.C., Rogers P.B., Besser G.M., Plowman P.N. Severe prolonged hypocalcemia following pamidronate for malignant hypercalcaemia. Clin Oncol. 10:1998;407-409.
17. McIntyre E., Bruera E. Symptomatic hypocalcemia after intravenous pamidronate. J Palliat Care. 12:1996;46-47.
18. Pedersen-Bjergaard U., Myhre J. Severe hypocalcemia after treatment with bisphosphonates and aminoglycosides. Br Med J. 302:1991;295.